Cardiac Health and Post COVID-19 Future
How learnings from COVID-19 can be applied to understanding the most destructive pandemic in human history: heart disease.
Latest News
Life by the Numbers: A Personal FH Journey
What is the impact of early diagnosis and appropriate treatment on disease management and longevity for individuals with familial hypercholesterolemia (FH) over the course of 45 years?
I answered this and many other questions in this research letter titled “Life by the Numbers: Living with Familial … Read More
Franco Americans, Familial Hypercholesterolemia and the Founder Effect
Large-scale research and genetic studies concur that familial hypercholesterolemia (FH) is a common genetic condition that impacts all races and ethnicities. In fact, it is estimated that 1 in 250 individuals worldwide have FH. That means, each of us reading this FH Foundation blog probably knows … Read More
Women and FH: Considerations for Care
Katherine Wilemon, founder and CEO of the FH Foundation, recently authored a paper with researchers from Stanford University that highlighted key differences in care for women with familial hypercholesterolemia (FH). The paper published in Current Atherosclerosis Reports highlights the unique needs … Read More
Early Signs of Heart Disease
So, what are some of the early signs of heart disease? And what should you do if you experience them? My advice, is to recommend that you seek medical attention, if you experience any of the following symptoms:
Chest Pain – often described as tightness, pressure, squeezing or aching beneath the … Read More
New Drug for Homozygous Familial Hypercholesterolemia Approved by the FDA
The Food and Drug Administration (FDA) approved today a new drug to treat adult and pediatric patients aged 12 years and older with Homozygous Familial Hypercholesterolemia (HoFH), the rare and most severe form of FH.This is welcome news, as individuals with HoFH usually are not able to adequately … Read More
ICER Report on Treatments for High Cholesterol – FH Foundation to Comment at Public Meeting February 5
The Institute for Clinical and Economic Review (ICER) – an organization that produces reports that analyze the cost effectiveness of drugs and other medical services – has highlighted the improved cost-effectiveness of high cholesterol treatments inclisiran and bempedoic acid in patients who have … Read More
Announcing partnership with Alliance for Million Hearts Campaign
The FH Foundation is proud to announce our partnership with the CDC Foundation as an inaugural community partner in the “Alliance for Million Hearts Campaign.” The campaign is a new public-private coalition with the nation’s leading organizations and thought leaders to confront the nation’s … Read More
Nutrition & Diet Tips for Managing Cholesterol
Living with high cholesterol or familial hypercholesterolemia may cause you to be on alert for nutrition/health related topics and rightly so. For those with FH, cholesterol lowering medication(s) is required to lower your cholesterol and LDL-C levels. You can’t eat your way to those high levels … Read More
FDA Listening Session for HoFH
The FH Foundation started 2021 off with an impactful Listening Session with the Food and Drug Administration (FDA) Center for Drug Evaluation and Research Division of Diabetes, Lipid Disorders, and Obesity (DDLO) on Homozygous Familial Hypercholesterolemia (HoFH) on January 4. Kate Robinson and … Read More